Compounds > o-(4-ethoxybutyl)berbamine
Page last updated: 2024-09-05

o-(4-ethoxybutyl)berbamine and Breast Cancer

o-(4-ethoxybutyl)berbamine has been researched along with Breast Cancer in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dai, XH; Fan, DM; Liu, R; Qi, J; Xiong, DS; Yang, CZ; Yang, M; Zhou, Y; Zhu, HF1
Cheng, YH; Liu, JW; Pan, B; Qi, J; Qi, SL; Xiong, DS; Yang, CZ; Zhu, HF1

Other Studies

2 other study(ies) available for o-(4-ethoxybutyl)berbamine and Breast Cancer

ArticleYear
[Effect of calmodulin antagonist O-4-ethoxyl- butyl-berbamine on the proliferation of human breast cancer cell line MCF-7 and its relevant mechanism].
    Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae, 2009, Volume: 31, Issue:3

    Topics: Benzylisoquinolines; Breast Neoplasms; Calmodulin; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Female; Humans

2009
[Reversal of multidrug resistance in drug-resistant human breast cancer cell line MCF-7/ADR by calmodulin antagonist O-(4-ethoxyl-butyl)-berbamine].
    Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae, 2006, Volume: 28, Issue:2

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzylisoquinolines; Breast Neoplasms; Calmodulin; Cell Cycle; Cell Line, Tumor; Doxorubicin; Drug Interactions; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans

2006